Sheffield Teaching Hospitals NHS Foundation Trust

• NCT04990791

  Phase 4, Completed, 48 people, 4 Aug 2021

• NCT03869268

  Phase 4, Completed, 72 people, 11 Mar 2019

• NCT02966652

  Collaborator, Phase 1, Completed, 25 people, 17 Nov 2016

• NCT02832648

  Phase 3, Completed, 123 people, 14 Jul 2016

• NCT02741817

  Phase 4, Completed, 20 people, 18 Apr 2016

• NCT02089542

  Phase 1/2, Completed, 41 people, 17 Mar 2014

• NCT01919294

  Phase 2, Completed, 3 people, 9 Aug 2013

• NCT01536964

  Phase 4, Completed, 12 people, 22 Feb 2012

• NCT01358669

  Phase 2, Completed, 24 people, 24 May 2011

• NCT01293292

  Phase 4, Completed, 19 people, 10 Feb 2011

• NCT00666627

  Phase 2, Completed, 410 people, 25 Apr 2008

• NCT00525759

  Phase 2, Completed, 40 people, 6 Sept 2007

• NCT00430794

  Phase 2, Terminated, 40 people, 2 Feb 2007

• NCT00220532

  Phase 1/2, Terminated, 180 people, 22 Sept 2005

• National Institute for Health and Care Research

  Research for Patient Benefit, Power Assisted Circuit Exercise for Stroke (PACE4S): A Refinement Study, NIHR208223, £204k, 2025–2027, 1 Jul 2025

• National Institute for Health and Care Research

  Programme Development Grants, PRO-FIT: Participatory Research for Optimising Faecal Immunochemical Test returns, enhancing bowel cancer detection and addressing health inequalities, NIHR208910, £256.2k, 2025–2027, 1 Apr 2025

• National Institute for Health and Care Research

  Efficacy and Mechanism Evaluation, Implementation of Metformin theraPy to Ease Decline of kidney function in Polycystic Kidney Disease (IMPEDE-PKD) Randomised Placebo-Controlled Trial, NIHR156614, £2.3m, 2024–2029, 1 Apr 2024

• National Institute for Health and Care Research

  Research for Patient Benefit, The clinical and cost-effectiveness of genetic screening in families with autosomal dominant polycystic kidney disease, NIHR204357, £228.9k, 2023–2026, 3 Jul 2023

• National Institute for Health and Care Research

  Research for Patient Benefit, Atrial Fibrillation After Resection (AFAR): A PROGRESS III Study, PB-PG-1217-20015, £350k, 2019–2026, 1 Jul 2019

• National Institute for Health and Care Research

  Programme Grants for Applied Research, Supported exercise TrAining for Men with prostate caNcer on Androgen deprivation therapy - STAMINA, RP-PG-1016-20007, £2.9m, 2018–2025, 3 Sept 2018

• National Institute for Health and Care Research

  Research for Patient Benefit, Is it feasible to conduct a randomised controlled trial of pre-transplant exercise (prehabilitation) for multiple myeloma patients awaiting autologous stem cell transplantation? (PREeMPT study), PB-PG-0214-33067, £186.5k, 2016–2018, 1 Apr 2016

Sources: fundingawards.nihr.ac.uk